BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2957 related articles for article (PubMed ID: 19710631)

  • 1. Neurocircuitry of addiction.
    Koob GF; Volkow ND
    Neuropsychopharmacology; 2010 Jan; 35(1):217-38. PubMed ID: 19710631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurobiology of addiction: a neurocircuitry analysis.
    Koob GF; Volkow ND
    Lancet Psychiatry; 2016 Aug; 3(8):760-773. PubMed ID: 27475769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addiction as a stress surfeit disorder.
    Koob GF; Buck CL; Cohen A; Edwards S; Park PE; Schlosburg JE; Schmeichel B; Vendruscolo LF; Wade CL; Whitfield TW; George O
    Neuropharmacology; 2014 Jan; 76 Pt B(0 0):370-82. PubMed ID: 23747571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocircuitry of alcohol addiction: synthesis from animal models.
    Koob GF
    Handb Clin Neurol; 2014; 125():33-54. PubMed ID: 25307567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors modulating neural reactivity to drug cues in addiction: a survey of human neuroimaging studies.
    Jasinska AJ; Stein EA; Kaiser J; Naumer MJ; Yalachkov Y
    Neurosci Biobehav Rev; 2014 Jan; 38():1-16. PubMed ID: 24211373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurobiological mechanisms and related clinical treatment of addiction: a review.
    Fang Y; Sun Y; Liu Y; Liu T; Hao W; Liao Y
    Psychoradiology; 2022 Dec; 2(4):180-189. PubMed ID: 38665277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor.
    Koob GF; Zorrilla EP
    Curr Opin Investig Drugs; 2010 Jan; 11(1):63-71. PubMed ID: 20047160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.
    Koob GF
    Pharmacol Rev; 2021 Jan; 73(1):163-201. PubMed ID: 33318153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurobiology of addiction. Toward the development of new therapies.
    Koob GF
    Ann N Y Acad Sci; 2000; 909():170-85. PubMed ID: 10911930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurobiological substrates for the dark side of compulsivity in addiction.
    Koob GF
    Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):18-31. PubMed ID: 18725236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical Frameworks and Mechanistic Aspects of Alcohol Addiction: Alcohol Addiction as a Reward Deficit/Stress Surfeit Disorder.
    Koob GF; Vendruscolo L
    Curr Top Behav Neurosci; 2023 Jul; ():. PubMed ID: 37421551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder.
    Koob GF
    Curr Top Behav Neurosci; 2013; 13():3-30. PubMed ID: 21744309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Existing and Future Drugs for the Treatment of the Dark Side of Addiction.
    Koob GF; Mason BJ
    Annu Rev Pharmacol Toxicol; 2016; 56():299-322. PubMed ID: 26514207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies.
    Volkow ND; Fowler JS; Wang GJ; Goldstein RZ
    Neurobiol Learn Mem; 2002 Nov; 78(3):610-24. PubMed ID: 12559839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurobiology of addiction: a neuroadaptational view relevant for diagnosis.
    Koob GF
    Addiction; 2006 Sep; 101 Suppl 1():23-30. PubMed ID: 16930158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.
    Koob GF
    Psychopharmacology (Berl); 2017 May; 234(9-10):1315-1332. PubMed ID: 28050629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addiction and stress: An allostatic view.
    Koob GF; Schulkin J
    Neurosci Biobehav Rev; 2019 Nov; 106():245-262. PubMed ID: 30227143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging pharmacotherapies for alcohol use disorder.
    Mason BJ
    Neuropharmacology; 2017 Aug; 122():244-253. PubMed ID: 28454983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain volume changes after long-term injectable opioid treatment: A longitudinal voxel-based morphometry study.
    Schmidt A; Vogel M; Baumgartner S; Wiesbeck GA; Lang U; Borgwardt S; Walter M
    Addict Biol; 2021 Jul; 26(4):e12970. PubMed ID: 33000891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory.
    Koob GF
    Pharmacopsychiatry; 2009 May; 42 Suppl 1(Suppl 1):S32-41. PubMed ID: 19434554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 148.